Related references
Note: Only part of the references are listed.Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski et al.
EPILEPSIA (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients
Lauren Treat et al.
EPILEPSIA (2017)
Interactions between cannabidiol and commonly used antiepileptic drugs
Tyler E. Gaston et al.
EPILEPSIA (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Forced Normalization: Antagonism Between Epilepsy and Psychosis
Yasuhiko Kawakami et al.
PEDIATRIC NEUROLOGY (2017)
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
Evan J. Hess et al.
EPILEPSIA (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Confusing placebo effect with natural history in epilepsy: A big data approach
Daniel M. Goldenholz et al.
ANNALS OF NEUROLOGY (2015)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
Craig A. Press et al.
EPILEPSY & BEHAVIOR (2015)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Measuring outcomes of treatment with antiepileptic drugs in clinical trials
Elinor Ben-Menachem et al.
EPILEPSY & BEHAVIOR (2010)
Catatonic psychosis related to forced normalization in a girl with Dravet's syndrome
Giuseppe Gobbi et al.
EPILEPTIC DISORDERS (2008)
Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs
Wolfgang Loescher et al.
EPILEPSIA (2006)
Share Paper
